Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258

CompletedOBSERVATIONAL
Enrollment

196

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Cancer
Interventions
BEHAVIORAL

Questionnaire

After informed consent for this study is obtained, patients will be given questionnaire #1 that includes rating their knowledge of the side effects of treatment, their understanding of the treatment schedule, what do in the event of complication, how to reach the medical team and an assessment of the level of anxiety. The questionnaire will be repeated at day 1 of the first chemotherapy treatment to assess the effectiveness of the teaching session. In addition, questionnaire #3 will be administered at day 1 of cycle 2 of their first chemotherapy.

Trial Locations (4)

02860

Memorial Hospital, Pawtucket

02903

Rhode Island Hospital (including Newport), Providence

02906

The Miriam Hospital, Providence

02908

Roger Williams Medical Center, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Rhode Island Hospital

OTHER

collaborator

The Miriam Hospital

OTHER

collaborator

Fatima Memorial Hospital

OTHER

collaborator

Roger Williams Medical Center

OTHER

collaborator

Lifespan

OTHER

lead

Brown University

OTHER

NCT01827761 - Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258 | Biotech Hunter | Biotech Hunter